MENU
+Compare
PTIX
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$0.44
Change
-$0.01 (-2.22%)
Capitalization
3.18M

PTIX Protagenic Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PTIX with price predictions
Jan 08, 2025

PTIX in -7.08% downward trend, declining for three consecutive days on January 08, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PTIX declined for three days, in of 222 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

PTIX moved below its 50-day moving average on December 20, 2024 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for PTIX entered a downward trend on January 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where PTIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on PTIX as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PTIX just turned positive on January 06, 2025. Looking at past instances where PTIX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PTIX advanced for three days, in of 160 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.421) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). PTIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.079).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PTIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSWCX12.270.11
+0.90%
Fidelity SAI US Value Index
GCSAX26.610.11
+0.42%
Goldman Sachs Small Cap Eq Insghts A
NINLX22.120.08
+0.36%
Neuberger Berman Intrinsic Value I
TSCPX12.620.04
+0.32%
AMG TimesSquare Small Cap Growth N
VDMCX8.460.01
+0.12%
Virtus KAR Developing Markets C

PTIX and Stocks

Correlation & Price change

A.I.dvisor tells us that PTIX and SCPX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTIX and SCPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
-2.01%
SCPX - PTIX
27%
Poorly correlated
-1.86%
SQZB - PTIX
26%
Poorly correlated
N/A
ALZN - PTIX
26%
Poorly correlated
+0.87%
ATXI - PTIX
25%
Poorly correlated
+5.71%
CDTX - PTIX
25%
Poorly correlated
+2.12%
More